Analyst Ratings for ALX Oncology (ALXO)
ALXO Rating Summary
ALXO Price Target Summary
- Highest: $6.00 (UBS)
- Lowest: $4.00 (Jefferies)
- Average: $4.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$4.60 (+200.7%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
Avg. $ Target:
$4.60 (+200.7%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/19/2026 | Wells Fargo | Derek Archila | New Coverage | Overweight (N/A) |
5.00 (N/A) |
2.15 (1.53) |
-28.84% | Details |
| 3/6/2026 | UBS | N/A | New Coverage | Buy (N/A) |
6.00 (N/A) |
2.13 (1.53) |
-28.17% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
